Affiliation: | 1. Division of Biomedical Engineering, James Watt School of Engineering, University of Glasgow, Glasgow, G12 8LT UK;2. Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, 0317 Norway Department of Pediatric Research, Oslo University Hospital, Oslo, 0317 Norway;3. Hybrid Technology Hub—Centre of Excellence, Institute of Basic Medical Sciences, University of Oslo, Oslo, 0317 Norway Department of Pediatric Research, Oslo University Hospital, Oslo, 0317 Norway Institute of Immunology, Oslo University Hospital, Oslo, 0317 Norway |
Abstract: | Microfluidics have been used for several decades to conduct a wide range of research in chemistry and the life sciences. The reduced dimensions of these devices give them advantages over classical analysis techniques such as increased sensitivity, shorter analysis times, and lower reagent consumption. However, current manufacturing processes for microfluidic chips either limit them to materials with unwanted properties, or are not cost-effective for rapid-prototyping approaches. Here the authors show that inlays for injection moulding can be 3D printed, thus reducing the skills, cost, and time required for tool fabrication. They demonstrate the importance of orientation of the part during 3D printing so that features as small as 100 × 200 µm can be printed. They also demonstrate that the 3D printed inlay is durable enough to fabricate at least 500 parts. Furthermore, devices can be designed, manufactured, and tested within one working day. Finally, as demonstrators they design and mould a microfluidic chip to house a plasmonic biosensor as well as a device to house liver organoids showing how such chips can be used in organ-on-a-chip applications. This new fabrication technique bridges the gap between small production and industrial scale manufacturing, while making microfluidics cheaper, and more widely accessible. |